COVID-19

Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial

En savoir plus

Chikungunya

En savoir plus

Maladie de Lyme

En savoir plus

C. difficile